Curis CRIS
NASDAQ CRIS
$1.20 -0.07 (-5.51%)
At close: Sep 9, 2026 · 4:00 PM EDT

Curis (CRIS) Accounts Payables (2010 - 2026)

Curis' (CRIS) quarterly Accounts Payables came in at $5.4 million in Q2 2026, up 31.51% on a YoY basis from $4.1 million in Q2 2025, and down 20.08% quarter-over-quarter from $6.7 million in Q1 2026.

Analysis

Curis (CRIS) Accounts Payables (2010 - 2026) Analysis & Trends

Curis (CRIS) has reported Accounts Payables for 17 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accounts Payables rose 31.51% year-over-year to $5.4 million; the trailing twelve-month figure through Jun 2026 stood at $5.4 million (up 31.51% YoY), and the FY2025 full-year result was $5.6 million, up 85.58% from the prior year.
  • Accounts Payables declined to $5.4 million in Q2 2026 per CRIS's latest filing, from $6.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $6.7 million in Q1 2026 and bottomed at $2.4 million in Q2 2024.
  • Historically, Accounts Payables has averaged $4.3 million across 5 years, with a median of $4.2 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Accounts Payables slumped 51.26% in 2023, then surged 85.58% in 2025.
  • Over 5 years, Accounts Payables stood at $3.2 million in 2022, then fell by 0.66% to $3.2 million in 2023, then dropped by 4.67% to $3.0 million in 2024, then soared by 85.58% to $5.6 million in 2025, then decreased by 3.99% to $5.4 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $5.4 million, $6.7 million, and $5.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.52 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 108.02 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 403.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 428.93 Mn
10 Curis 2.63 Mn -2.99 Mn - 5.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.39 Mn
Mar 31, 2026 6.74 Mn
Dec 31, 2025 5.61 Mn
Sep 30, 2025 4.45 Mn
Jun 30, 2025 4.10 Mn
Mar 31, 2025 5.10 Mn
Dec 31, 2024 3.02 Mn
Sep 30, 2024 3.82 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 3.63 Mn
Dec 31, 2023 3.17 Mn
Sep 30, 2023 5.22 Mn
Jun 30, 2023 2.69 Mn
Mar 31, 2023 2.64 Mn
Dec 31, 2022 3.19 Mn
Sep 30, 2022 5.76 Mn
Jun 30, 2022 5.51 Mn
Mar 31, 2022 4.28 Mn
Dec 31, 2021 6.42 Mn
Sep 30, 2021 3.51 Mn